Although malaria is preventable and curable, half the world's population is still at risk and 438,000 people die from the disease every year. Concerted global action and investment by the public health community have already saved millions of lives: cases have fallen by 37% since 2000 and death rates by 58% - more than 6.2 million lives, primarily young children, have been saved. However, the issue of growing resistance to public health insecticides could threaten the progress of recent years.
Beating the threat of increasing insecticide resistance
Chlorfenapyr – a new approach
Mosquito resistance to at least one insecticide used for malaria control has already been identified in 53 malaria-endemic countries. Our public health team is working with the World Health Organization, the Bill and Melinda Gates Foundation and international research institutes such as the Innovative Vector Control Consortium, the London School of Health and Tropical Medicine and the Liverpool School of Tropical Medicine, to bring two new resistance management products based on chlorfenapyr, a completely new active ingredient for the public health sector, to the market.
A new generation of BASF’s Interceptor® mosquito net, called Interceptor® G2, and Sylando® 240SC, an indoor residual spray to coat walls and ceilings of homes, are currently undergoing trials through the WHO Pesticide Evaluation Scheme (WHOPES).
Editorial feature on new products
To mark World Malaria Day, BASF published a new editorial feature that looks at insecticide resistance in public health, talks to leading researchers working on resistance management and previews the two new chlorfenapyr products.
Download the feature here (column right) or from our publications section.